- Home
- SLS vs SANG Comparison
SLS vs SANG Comparison
Compare SLS & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- SANG
- Stock Information
- Founded
- SLS 2012
- SANG 1984
- Country
- SLS United States
- SANG Canada
- Employees
- SLS N/A
- SANG N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- SLS Health Care
- SANG Technology
- Exchange
- SLS Nasdaq
- SANG Nasdaq
- Market Cap
- SLS 165.6M
- SANG 194.3M
- IPO Year
- SLS N/A
- SANG 2021
- Fundamental
- Price
- SLS $1.91
- SANG $5.74
- Analyst Decision
- SLS Strong Buy
- SANG
- Analyst Count
- SLS 1
- SANG 0
- Target Price
- SLS $7.00
- SANG N/A
- AVG Volume (30 Days)
- SLS 1.8M
- SANG 1.6K
- Earning Date
- SLS 08-12-2025
- SANG 09-17-2025
- Dividend Yield
- SLS N/A
- SANG N/A
- EPS Growth
- SLS N/A
- SANG N/A
- EPS
- SLS N/A
- SANG N/A
- Revenue
- SLS N/A
- SANG $238,264,000.00
- Revenue This Year
- SLS N/A
- SANG N/A
- Revenue Next Year
- SLS N/A
- SANG $2.38
- P/E Ratio
- SLS N/A
- SANG N/A
- Revenue Growth
- SLS N/A
- SANG N/A
- 52 Week Low
- SLS $0.77
- SANG $4.08
- 52 Week High
- SLS $2.27
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- SLS 60.77
- SANG 47.96
- Support Level
- SLS $1.50
- SANG $5.65
- Resistance Level
- SLS $1.77
- SANG $5.80
- Average True Range (ATR)
- SLS 0.11
- SANG 0.08
- MACD
- SLS 0.04
- SANG 0.00
- Stochastic Oscillator
- SLS 97.62
- SANG 68.75
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.